Abstract
Purpose. To determine the effect of protein concentration on aggregation induced through quiescent shelf-life incubation or shipping-related agitation.
Methods. All aggregation was measured by size-exclusion high-performance liquid chromatography. Aggregation was induced by time-dependent incubation under stationary conditions or by agitation caused by shaking, vortexing, or vibration using simulated shipping conditions.
Results. Protein aggregation is commonly a second- or higher-order process that is expected to increase with higher protein concentration. As expected, for three proteins (PEG-GCSF, PEG-MGDF, and OPG-Fc) that were examined, the aggregation increased with higher protein concentration if incubated in a quiescent shelf-life setting. However, aggregation decreased with higher protein concentration if induced by an air/water interface as a result of agitation. This unexpected result may be explained by the rate-limiting effect on aggregation of the air/water interface and the critical nature of the air/water interface to protein ratio that is greatest with decreased protein concentration. The non-ionic detergent polysorbate 20 enhanced the aggregation observed in the quiescently incubated sample but abrogated the aggregation induced by the air/water interface.
Conclusions. The effect of protein concentration was opposite for aggregation that resulted from quiescent shelf-life treatment compared to induction by agitation. For motionless shelf-life incubation, increased concentration of protein resulted in more aggregation. However, exposure to agitation resulted in more aggregation with decreased protein concentration. These results highlight an unexpected complexity of protein aggregation reactions.
Similar content being viewed by others
REFERENCES
M. C. Manning, K. Patel, and R. Borchardt. Stability of protein pharmaceuticals. Pharm. Res. 6:903–918 (1989).
J. L. Cleland, M. Powell, and S. Shire. The development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation. Crit. Rev. Ther. Drug Carrier Syst. 10:307–377 (1993).
J. F. Carpenter, B. S. Kendrick, B. S. Chang, M. C. Manning, and T. W. Randolph. Inhibition of stress-induced aggregation of protein therapeutics. In R. Wetzel (ed.), Methods in Enzymology, vol. 309, Academic Press, San Diego, California, 1999 pp. 236–255 (1999).
N. K. Adam. In The Physics and Chemistry of Surfaces, Oxford University Press, London, 1941.
A. Rothen. Films of protein in biologic processes. Adv. Protein Chem. 3:123–128 (1947).
D. F. Cheesman and J. T. Davies. Physicochemical and biologic aspects of proteins at interfaces. Adv. Protein Chem. 9:439–498 (1954).
R. Wetzel. Amyloid, prions, and other protein aggregates. In Methods in Enzymology, vol. 309, Academic Press, San Diego, California, 1999.
A. L. Fink. Protein aggregation: folding aggregates, inclusion bodies and amyloid. Folding & Design 3:R9–R23 (1998).
D. Gidalevitz, H. Zhengoing, and S. A. Rice. Protein folding at the air-water interface studied with X-ray reflectivity. Proc. Natl. Acad. Sci. USA 96:2608–2611 (1999).
B. A. Kerwin, M. C. Heller, S. H. Levin, and T. W. Randolph. Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at-20C of a recombinant hemoglobin. J. Pharm. Sci. 87:1062–1068 (1998).
R. Lumry and H. Eyring. Conformation changes of proteins. J. Phys. Chem. 58:110–120 (1954).
G. Zettlmeissl, R. Rudolph, and R. Jaenicke. Reconstitution of lactic dehydrogenase. Biochemistry 18:5567–5571 (1979).
T. D. Bartley, J. M. Bogenberger, R. A. Bosselman, P. Hunt, O. B. Kinstler, and B. B. Smal. Compositions and Methods for stimulating megakaryocyte growth and differentiation. World Patent Publication 26:746–918 (1995).
American Society for Testing and Materials. Standard test method for random vibration testing of shipping containers. D 4728-91, 287-291 (ASTM Committee on Standards, 1916 Race St., Philadelphia, Pennsylvania 19103, approved Dec. 15, 1991).
A. F. Henson, J. R. Mitchell, and P. R. Musselwhite. The surface coagulation of proteins during shaking. J. Colloid Interface Sci. 32:162–165 (1970).
T. L. Donaldson, E. F. Boonstra, and J. M. Hammond. Kinetics of protein denaturation at gas-liquid interfaces.J. Colloid Interface Sci. 74:441–450 (1980).
F. MacRitchie. Spread monolayers of proteins. Adv. Colloid Interface Sci. 25:341–385 (1986).
V. Vogel. Fibronectin in a surface-adsorbed state: Insolubilization and self-assembly. In T.A. Horbet and J.L. Brash (eds.), Protein at interfaces II: fundamentals and applications, ACS Symposium series, American Chemical Society, Washington, DC, 1995, 602: pp. 505–518.
Y.-F. Maa and C. C. Hsu. Protein denaturation by combined effect of shear and air-liquid interface. Biotech. Bioeng. 54:503–512 (1997).
H. L. Levine, T. C. Ransohoff, R. T. Kawahata, and W. C. Mc-Gregor. The use of surface tension measurements in the design of antibody-based product formulations. J. Par. Sci. Tech. 45:160–165 (1991).
R. W. Niven, S. J. Prestrelski, M. J. Treuheit, A. Y. Ip, and T. Arakawa. Protein nebulization II. Stabilization of G-CSF to airjet nebulization and the role of protectants. Int. J. Pharm. 127: 191–201 (1996).
E. Ibanoglu and S. Ibanoglu. Foaming behavior of EDTA-treated ?-lactalbumin. Food Chem. 66:477–481 (1999).
A. Millqvist-Fureby, M. Malmsten, and B. Bergenstahl. Spray-drying of trypsin, surface characterisation and activity preservation. Int. J. Pharm. 188:243–253 (1999).
R. J. Greem, T. J. Su, H. Joy, and J. R. Lu. Interaction of lysozyme and sodium dodecyl sulfate at the air-liquid interface. Langmuir 16:5797–5805 (2000).
L. Bush, C. Webb, L. Bartlett, and B. Burnett. The formulation of recombinant factor IX: Stability, robustness, and convenience. Semin. Hematol. 35:18–21 (1998).
Y.-F. Maa, P.-A. T. Nguyen, and S. W. Hsu. Spray-drying of air-liquid interface sensitive recombinant human growth hormone. J. Pharm. Sci. 87:152–159 (1998).
M. Katakam and A. K. Banga. Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses. Pharm. Dev. Tech. 2:143–149 (1997).
S. A. Charman, K. L. Mason, and W. N. Charman. Techniques for assessing the effects of pharmaceutical excipients on the aggregation of porcine growth hormone. Pharm. Res. 10:954–962 (1993).
M. DeFelippis, L. A. Alter, A. H. Pekar, H. A. Havel, and D. N. Brems. Evidence for a self-associating equilibrium intermediate during folding of human growth hormone. Biochemistry 32:1555–1562 (1993).
N. B. Bam, J. L. Cleland, and T. W. Randolph. Molten globule intermediate of recombinant human growth hormone: Stabilization with surfactants. Biotechnol. Prog. 12:801–809 (1996).
N. B. Bam, J. L. Cleland, J. Yang, M. C. Manning, J. F. Carpenter, R. F. Kelley, and T. W. Randolph. Tween protects recombinant human growth hormone agitation-induced damage via hydrophobic interactions. J. Pharm. Sci. 87:1554–1559 (1998).
V. Sluzky, J. A. Tamada, A. M. Klibanov, and R. Langer. Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc. Natl. Acad Sci. USA 88:9377–9381 (1991).
V. Sluzky, A. M. Klibanov, and R. Langer. Mechanism of Insulin aggregation and stabilization in agitated aqueous solutions. Biotechnol. Bioengin. 40:895–903 (1992).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Treuheit, M.J., Kosky, A.A. & Brems, D.N. Inverse Relationship of Protein Concentration and Aggregation. Pharm Res 19, 511–516 (2002). https://doi.org/10.1023/A:1015108115452
Issue Date:
DOI: https://doi.org/10.1023/A:1015108115452